A carregar...
ASA404, a vascular disrupting agent, as an experimental treatment approach for brain tumors
Malignant brain tumors, including gliomas, brain metastases and anaplastic meningiomas, are associated with poor prognosis, and represent an unmet medical need. ASA404 (DMXAA), a vascular disrupting agent, has demonstrated promising results in several preclinical tumor models and early phase clinica...
Na minha lista:
| Publicado no: | Oncol Lett |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5652230/ https://ncbi.nlm.nih.gov/pubmed/29098034 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6832 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|